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I. introduction 
Although the function of the methylated nucleo- 
sides in tRNA is not well understood numerous papers 
have suggested that methylation of tRNA may be of 
importance in cellular regulatory mechanisms ince 
alterations in the activities of tRNA methylases 
assayed in vitro have been detected in many tissues 
undergoing changes in growth or differentiation under 
a variety of stimuli [l-l 0] . Recently several authors 
have reported that inhibitors of these enzymes are 
present in some tissues and that the changes in the 
activities of tRNA methylases may be brought about 
by alterations in the concentration of such inhibitors 
[g-lo]. The nature of these naturally occurring in- 
hibitors is not yet clearly defined and only limited experi- 
mental data on compounds inhibiting tRNA methylases 
of mammalian cells have been published [ 3,11, 121. 
The availability of a potent inhibitor of tRNA methyl- 
ase activity may provide a useful means of investigating 
the role of methylation in the function of tRNA and 
the growth of the cell. 
This paper describes the effects of a number of 
compounds related to S-adenosyl-Lmethionine (AMe) 
on the activity of tRNA methylases isolated from rat 
liver and kidney. S-Adenosyl-L-homocysteine (AH) 
was found to be a potent inhibitor of methylation 
when present at concentrations of the same order as 
AMe and could have an effect on the methylation of 
nucleic acid in vivo. 
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2. Materials and methods 
SAdenosyl-L[Me-r4C] -methionine (AMe-14CHs) 
was purchased from The Radiochemical Centre, 
Amersham, and purified and stored as previously 
described [ 131 . S-Adenosyl-L-ethionine (AEt) and 
Se-adenosyl-L-selenomethionine (SeAMe) were pre- 
pared from the amino acids by the action of 
ATP: L-methionine S-adenosyltransferase [ 13, 141. 
S-Adenosyl-Lhomocysteine was purchased from 
Boehringer Corp. (London) Ltd. LEthionine, 
Lmethionine, L-selenomethionine and S-methyl-L- 
methionine were products of Sigma Chem. Co., 
London. S-Trifluoromethyl-L-homocysteine was 
obtained from Cycle Chem. Corp., USA and tRNAfMet 
from E. coli K 12 was a gift from Oak Ridge National 
Laboratory, N.I.H., USA. 
Tissue extracts containing tRNA methylase were 
prepared from homogenates of rat liver and kidney 
and assayed as described by Pegg [ 151. The assay 
medium contained 15 pmoles tris-HCl pH 8.8,4 
moles putrescine, 50 pg of tRNA from E. coli K 12 
or 250 pmoles tRNAfMet, 0.2-0.5 mg enzyme protein 
and AMe-14CHs and the compounds tested as inhibi- 
tors in a total volume of 0.15 ml. After incubation at 
37” for 15 min aliquots were removed and the methyl- 
ation of tRNA determined [15] . 
3. Results 
When incubated under the conditions described 
above and in the presence of 25 PM AMe-14CH3, 
enzymes isolated from rat liver and kidney catalysed 
the methylation of bacterial tRNA at a rate which was 
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Fig. 1. Effect of AEt on methylation of tRNA by liver ex- 
tracts. The assay medium contained 25 PM AMe-14CH3 (0) 
or 10 @M AMe-14CH3 (o), 50 pg tRNA and 0.3 mg of liver 
protein. 
proportional to the amount of protein added and to 
the time of incubation for at least 30 min. LMethionine 
(100 mM), L-ethionine (100 mM), adenosine (20 ml@, 
S-methyl-L-methionine (10 mM) and S-trifluoromethyl- 
Lhomocysteine (5 mM) had no effect on the methyl- 
ation of tRNA when added to the assay medium at 
the concentrations shown. However, AEt, AH and 
SeAMe were effective in decreasing the transfer of 
radioactivity from AMe-14CH3 to tRNA. 
As shown in fig. 1, AEt inhibited the methylation 
of tRNA but this sulphonium compound although 
closely related to AMe was not a particularly potent 
inhibitor since a concentration 30-40 times greater 
than that of the AMe-14CH3 present was required to 
achieve 50% inhibition. AH was a far more potent in- 
hibitor of the methylation of tRNA by rat liver 
enzymes than AEt (fig. 2). 50% inhibition of the rate 
of methylation of tRNA was produced by concentra- 
tions of AH only 2-3 times greater than that of the 
AMe-14CHS. The inhibitory effect of AH was lessened 
at high concentrations of AMe-14CH3 suggesting that 
inhibition was of the competitive type. However, the 
data obtained by varying the concentration of AMe 
or AH and measuring the reaction velocity did not 
give simple graphical plots showing competitive inhi- 
bition. This finding is not unexpected since the methyl- 
ation of unfractionated bacterial tRNA by a crude rat 
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Fig. 2. Effect of AH on methylation of tRNA by liver extracts. 
The assay medium contained 22 PM (o), 9 JJM (0) or 4.5 ctM 
(v) AMe-14CH3, 50 fig tRNA and 0.4 mg pf liver protein. 
liver extract is made up of the actions of a number of 
enzymes producing a variety of methylated bases at a 
number of sites within the tRNA mixture added [ l- 
lo]. These enzymes may well have certain features in 
common and indeed all are inhibited in the presence 
VAMe (mM_‘) 
Fig. 3. Double reciprocal plot of methylation of tRNA against 
AMe-14CH3 concentration in the presence of 10 PM SeAMe 
(o), 7.5 PM AH (o) or no addition (v). The assay medium 
contained 250 pmoles tRNAmet and 0.6 mg of kidney protein. 
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of sufficiently high levels of AEt or AH but it is most 
unlikely that all have similar affinities for AMe and 
the inhibitors. 
Purification of mammalian tRNA methylases has 
been hampered by the unstable nature of the enzymes 
and by the unavailability of the correct substrate (un- 
methylated mammalian tRNA) [l-3] Since extensive 
purification of a particular tRNA methylase from a 
tissue extract cannot easily be accomplished without 
considerable loss of the original activity such a proce- 
dure is not suitable for estimations of any changes in 
the activity of the enzyme in developing or growing 
tissues. One approach which may prove useful in this 
respect is to use as a substrate for methylation a highly 
purified tRNA fraction which contains nucleotide 
sequences uitable for methylation by only one 
enzyme present in the tissue. Purified tRNAfMe* from 
E. co/i was methylated by an enzyme extract prepared 
from rat kidney and the total extent of methylation 
in the presence of excess enzyme was approximately 
equal to 1 pmole per pmole of tRNAfMet added. 
Preliminary evidence suggests that the product of this 
reaction is 1-methylguanine (Pegg, unpublished ob- 
servations). The methylation of tRNAfMe* by such 
kidney extracts was inhibited by AH and as shown in 
fig. 3 linear plots of the reciprocal of the AMe-14CHs 
concentration with the reciprocal of the reaction 
velocity were obtained with this system. The Km for 
AMe was 3 PM and the Kj for AH was 7 PM. The 
analogue of AMe in which the sulphur atom is replaced 
by selenium was also found to be a potent competitive 
inhibitor of the methylation of tRNAme* (fig. 3). The 
Ki for SeAMe was found to be 5 m. 
Reaction of the amino group of the homocysteine 
moiety of AH with ethylchloroformate or p-nitro- 
phenylchloroformate completely abolished the in- 
hibitory activity. Similarly AMe in which the amino 
group of the methionine had been reacted with either 
of these compounds was no longer active as a methyl 
donor for tRNA methylases and had no effect on the 
rate of methylation of tRNA when AMe-14CHs was 
available even when present at concentrations 100 
times that of AMe-14CH 3. 
4. Discussion 
The observations reported here utilising a crude 
preparation containing a number of tRNA methylases 
allow certain general conclusions concerning the 
requirements for inhibitors related tr> the methyl 
donor, AMe, to be made. These can be summarised as 
follows: (i) such compounds must have both an 
adenosyl and an amino acid moiety, (ii) the amino 
group of the amino acid must be free, (iii) the sul- 
phonium centre is not obligatory but can be replaced 
by Se+ or by the sulphur atom of AH and (iv) 
replacing the methyl group by an ethyl moiety has a 
much greater effect in reducing the activity of the in- 
hibitor than removing the group completely (AH) or 
substituting the selenium atom for sulphur. 
The three adenosyl derivatives found to affect the 
methylation of tRNA in vitro are all known to occur 
in rat liver under appropriate conditions and could 
therefore influence the methylation of nucleic acids 
in vivo. AEt accumulates in the livers of rats which had 
been treated with ethionine [ 161. This compound can 
act as an ethyl donor in a number of enzymic reactions 
but, in general, the rate of reaction is considerably 
less than that of AMe [ 14, 161 . AEt is a substrate for 
some but not all of the tRNA methylases of rat liver 
and the rate of ethylation is less than 5% that of 
methylation [ 171 . It is possible that the thylation of 
nucleic acids may be of importance in producing the 
physiological changes induced by ethionine administra- 
tion [ 181 but the possible inhibition of methylation 
without consequent incorporation of ethyl groups at 
the nucleotide sites normally methylated should also 
be considered. 
LSelenomethionine is extremely toxic to rats and 
is known to be converted to the adenosyl derivative 
in the liver [ 181 . The selenium analogue of AMe has 
been found to be as active as AMe itself in reactions 
forming polyamines [ 141 and in certain methyl 
transfer reactions [ 18-201 . SeAMe may therefore be 
an active substrate for tRNA methylases. Further in- 
vestigation of this possibility would require L-seleno- 
methionine labelled in the methyl group. If SeAMe is 
able to replace AMe in this reaction the administration 
of Lselenomethionine would have little or no effect 
on the methylation of nucleic acids but if some or all 
of the tRNA methylases do not transfer methyl groups 
from SeAMe, administration of this amino acid 
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analogue my lead to the formation of ‘under- 
methylated’ tRNA. 
Stekol has reported that S-trifluoromethyl-L- 
homocysteine WRS converted to S-adenosyl-L-tri- 
fluoromethyl-homocysteine by rat liver enzymes in 
vitro and in vivo and that after the administration of 
this amino acid to rats the transfer of methyl groups 
from AMe in vivo was decreased possibly by the in- 
hibition of one or more transmethylation reactions by 
S-adenosyl-L-trilluoromethyl-homocysteine [ 181. 
$Trifluoromethyl-L-homocysteine had no effect on 
the methylation of tRNA in vitro and it was not pos- 
sible to confirm the finding that this amino acid could 
be converted to an adenosyl derivative using Wistar 
rats from the strain bred in this Institute. Therefore 
the effects of this analogue of AMe on tRNA methyl- 
ases could not be tested. Recently another report that 
S-trifluoromethyl-L-homocysteine could not be con- 
verted to the adenosyl derivative by an enzyme derived 
from rat liver has been published [2 1 ] 
The competitive inhibition of tRNA methylases 
by AH which is a product of the reaction has also been 
found to occur with enzymes isolated from E. coli W 
[22] . The physiological significance of this inhibition 
is dependent on the relative levels of AMe and AH 
within the cell. The AH content of normal rat liver 
is 0.06 mole/g wet tissue and is approximately equal 
to that of AMe [23] . It is therefore possible that in 
this tissue AH does exert some effect on the rate of 
methylation of tRNA and the AH present in un- 
dialysed extracts prepared from rat liver could have 
an inhibitory action on tRNA methylase activity 
measured in vitro. The AH present in liver homogenates 
could be at least partially responsible for the decreased 
tRNA methylase activity when liver extracts were 
added to tumour extracts [lo] , although, very recently, 
mcotinamide has been found to be an inhibitor of the 
methylation of tRNA and this compound may be 
responsible for all or part of the inhibitory activity 
Present in liver extracts [ 1 11. However, it should be 
noted that under normal metabolic conditions there is 
no Pool of ‘under-methylated’ tRNA in rat liver [3] 
and hence the activity of tRNA methylases in vivo is 
sufficient to ensure complete methylation of tRNA. 
“fhe demonstration that inhibitors of these enzymes 
are Present in tissue extracts assayed in vitro [8-l l] 
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